Cambrex Corporation (CBM) : The short interest in Cambrex Corporation (CBM) has changed with an increase of 79,575 shares and the open interest is 3.3%. From 2,379,892 short positions on Jul 29, 2016, the shorts increased to 2,459,467 shares by August 15, 2016. There are 7 more days left for the expiry and the daily trading volume of the stock is 330,142 shares. The total interest of shorts is 7.8% of the shares available to the public. The short interest information was released on Wednesday Aug 24th after the market close.
Cambrex Corporation (NYSE:CBM): The stock opened at $44.53 on Wednesday but the bulls could not build on the opening and the stock topped out at $45.13 for the day. The stock traded down to $43.85 during the day, due to lack of any buying support eventually closed down at $44.12 with a loss of -0.83% for the day. The stock had closed at $44.49 on the previous day. The total traded volume was 621,139 shares.
In a related news,The director of Cambrex Corp, Korb William B sold 3,420 shares at $55 on July 11, 2016. The Insider selling transaction had a total value worth of $188,100. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Cambrex Corporation (Cambrex) is a life sciences company that provides products and services for the development and commercialization of new and generic therapeutics. The Company supplies its products and services worldwide to innovator and generic pharmaceutical companies. The Companys customers include generic drug companies and companies that discover and commercialize small molecule human therapeutics using organic chemistry. Its business consists of the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. The Companys products include active pharmaceutical ingredients (APIs), pharmaceutical intermediates and, to a lesser extent, other fine chemicals. Cambrex has three operating segments, which are manufacturing facilities that have been aggregated as one reportable segment.